Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 388

Sort by

Sort Order Select

Journal Articles

Improved outcomes and treatment guidance in pediatric therapy-related AML: AML-BFM study group recommendations

Stephanie Sendker, Markus Schneider, Evangelia Antoniou, Daniel Neumann, Naghmeh Niktoreh, Uta Dirksen, Nils von Neuhoff, Ursula Creutzig, Dirk Reinhardt, Katharina Waack

Blood Adv (2025) 9 (11): 2831–2841.

https://doi.org/10.1182/bloodadvances.2024014728

Published: 2025

Includes: Supplemental data

Journal Articles

Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease

Kristine Karkoska, Seethal A. Jacob, Patrick T. McGann

Blood Adv (2025) 9 (11): 2857–2862.

https://doi.org/10.1182/bloodadvances.2025015822

Published: 2025

Journal Articles

On the road to improved therapies for therapy-related AML

Alexandra McLean Stevens, Todd M. Cooper

Blood Adv (2025) 9 (11): 2842–2844.

https://doi.org/10.1182/bloodadvances.2025015987

Published: 2025

Journal Articles

Implementing ASH’s guidelines for acute medical care for incarcerated children and adults with sickle cell disease

Michael R. DeBaun, Michelle Staples-Horne, Radha Sadacharan, Paula Braverman, Nirmish Shah, John Strouse, Deana Orsini, Charles Dudley Lee, Elizabeth S. Barnert

Blood Adv (2025) 9 (11): 2744–2750.

https://doi.org/10.1182/bloodadvances.2023012546

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy

Blood Adv (2025) 9 (11): 2763–2772.

https://doi.org/10.1182/bloodadvances.2024014846

Published: 2025

Includes: Supplemental data

Journal Articles

Clinical outcomes in older adults treated outside clinical studies: highlighting the octogenarian experience

Dor Shpitzer, Yael C. Cohen, Tamir Shragai, Ori Grossberger, Dana Amsterdam, Anat Reiner-Benaim, Irit Avivi

Blood Adv (2025) 9 (11): 2677–2685.

https://doi.org/10.1182/bloodadvances.2025015968

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy

Jibran Durrani, Leonard N. Chen, Ruba N. Shalhoub, Valentina Baez, Joshua Glass, Nu Ri Cha, Xiaoyang Ma, Zhijie Wu, Shouguo Gao, Jennifer Lotter, Olga Rios, Colin O. Wu, Willy A. Flegel, Neal S. Young, Emma M. Groarke, Bhavisha A. Patel

Blood Adv (2025) 9 (11): 2639–2650.

https://doi.org/10.1182/bloodadvances.2024015301

Published: 2025

Includes: Supplemental data

Journal Articles

Weighing the evidence on GLP1s and venous thromboembolism

Damon E. Houghton, Karlyn A. Martin

Blood Adv (2025) 9 (10): 2458–2459.

https://doi.org/10.1182/bloodadvances.2025016052

Published: 2025

Journal Articles

Inaccuracies of Venous Thromboembolism Risk Assessment and Prevention Practices Among Medically Ill Patients

Brandyn Lau, Aditya Bhave, Jennifer C Yui, Rakhi P. Naik, Kathryn E. Dane, John P Lindsley, Dauryne Shaffer, Peggy S Kraus, Erik H Hoyer, Elliott R Haut, Michael B. Streiff

Blood Adv bloodadvances.2024015306.

https://doi.org/10.1182/bloodadvances.2024015306

Published: 2025

Includes: Supplemental data

Journal Articles

Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study

Xavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros, Roberta Di Blasi, Charles Herbaux, Jacques Olivier Bay, Sylvain Carras, Pierre Bories, Olivier Casasnovas, Fabrice Jardin, Franck Morschhauser, Blandine Guffroy, Mohamad Mohty, Elodie Gat, Julien Calvani, Marie-Cécile Parrens, Elsa Poullot, Alexandra Traverse-Glehen, Louise Roulin

Blood Adv (2025) 9 (10): 2500–2510.

https://doi.org/10.1182/bloodadvances.2024014732

Published: 2025

Includes: Supplemental data

Journal Articles

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France

Blood Adv (2025) 9 (10): 2530–2541.

https://doi.org/10.1182/bloodadvances.2024015208

Published: 2025

Includes: Supplemental data

Journal Articles

Inequalities in CAR T-Cell Therapy Access for US Patients with Relapsed/Refractory DLBCL: A SEER-Medicare Data Analysis

Andrea Chung, Jason Shafrin, Sachin Vadgama, Kristen Hurley, Miguel-Angel Perales, Leonard Clarkson Alsfeld, Sanjana Muthukrishnan, Anik R Patel, Gunjan L Shah, Richard T. Maziarz

Blood Adv bloodadvances.2024015634.

https://doi.org/10.1182/bloodadvances.2024015634

Published: 2025

Includes: Supplemental data

Journal Articles

Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencing

Ting Wen, Steven E. Boyden, Caleb M. Hocutt, Robert G. Lewis, Erin E. Baldwin, Jennie Vagher, Ashley Andrews, Thomas J. Nicholas, Alexander Chapin, Elaine M. Fan, Lorenzo D. Botto, Pinar Bayrak-Toydemir, Rong Mao, Jessica A. Meznarich

Blood Adv (2025) 9 (10): 2443–2452.

https://doi.org/10.1182/bloodadvances.2024015347

Published: 2025

Includes: Supplemental data

Journal Articles

What to do with the weight while preparing for CAR-T?

Samuel J. Yates, Ishan Roy

Blood Adv (2025) 9 (10): 2419–2421.

https://doi.org/10.1182/bloodadvances.2024015429

Published: 2025

Journal Articles

Cytogenetic annotation automation in myelodysplastic syndrome research databases

Samuel Urrutia, Kelly S. Chien, Ziyi Li, Alexandre Bazinet, Guilin Tang, Guillermo Garcia-Manero

Blood Adv (2025) 9 (10): 2428–2430.

https://doi.org/10.1182/bloodadvances.2024015362

Published: 2025

Includes: Supplemental data

Journal Articles

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT

Shunto Kawamura, Daishi Nakagawa, Takashi Nagayama, Yuta Katayama, Noriko Doki, Wataru Takeda, Tetsuya Nishida, Ken-ichi Matsuoka, Takashi Ikeda, Hiroyuki Ohigashi, Masashi Sawa, Kentaro Fukushima, Junya Kanda, Kentaro Serizawa, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Yoshinobu Kanda, Hideki Nakasone

Blood Adv (2025) 9 (9): 2356–2365.

https://doi.org/10.1182/bloodadvances.2024014408

Published: 2025

Includes: Supplemental data

Journal Articles

Is transplant success linked to donor CMV serostatus?

Steven M. Devine

Blood Adv (2025) 9 (9): 2354–2355.

https://doi.org/10.1182/bloodadvances.2025015934

Published: 2025

Journal Articles

Finding the right fit: assessment of fitness in AML

Nicholas Chornenki, Lee Mozessohn

Blood Adv (2025) 9 (9): 2300–2301.

https://doi.org/10.1182/bloodadvances.2025016114

Published: 2025

Journal Articles

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Blood Adv (2025) 9 (9): 2207–2220.

https://doi.org/10.1182/bloodadvances.2024013744

Published: 2025

Includes: Supplemental data

Journal Articles

Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma

Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, John D. Shaughnessy, Jr., Fenghuang Zhan, Eric R. Siegel, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi

Blood Adv (2025) 9 (9): 2155–2158.

https://doi.org/10.1182/bloodadvances.2024015648

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Improved outcomes and treatment guidance in pediatric therapy-related AML: AML-BFM study group recommendations

Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease

On the road to improved therapies for therapy-related AML

Implementing ASH’s guidelines for acute medical care for incarcerated children and adults with sickle cell disease

Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy

Clinical outcomes in older adults treated outside clinical studies: highlighting the octogenarian experience

Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy

Weighing the evidence on GLP1s and venous thromboembolism

Inaccuracies of Venous Thromboembolism Risk Assessment and Prevention Practices Among Medically Ill Patients

Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France

Inequalities in CAR T-Cell Therapy Access for US Patients with Relapsed/Refractory DLBCL: A SEER-Medicare Data Analysis

Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencing

What to do with the weight while preparing for CAR-T?

Cytogenetic annotation automation in myelodysplastic syndrome research databases

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT

Is transplant success linked to donor CMV serostatus?

Finding the right fit: assessment of fitness in AML

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only